The goal of this clinical trial is to evaluate the diagnostic effcacy and safety of ultrasound elastography guided pleural biopsy in the differential diagnosis of benign and malignant pleural effusion. The main question it aims to answer are: the effectiveness and safety of ultrasound elastography guided pleural biopsy in the differential diagnosis of benign and malignant pleural effusion. Participants will undergo ultrasound elastography guided pleural biopsy or traditional ultrasound-guided pleural biopsy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
592
The patients will undergo ultrasound elastography (Aixplorer V, SuperSonic Imagine, FRA) guided pleural biopsy.
The patients will undergo traditional ultrasound (Aixplorer V, SuperSonic Imagine, FRA) guided pleural biopsy.
Anhui Chest Hospital
Hefei, Anhui, China
RECRUITINGChina-Japan Friendship Hospital
Beijing, Beijing Municipality, China
RECRUITINGGui Zhou Provincial People's Hospital
Guiyang, Guizhou, China
RECRUITINGthe Second Xiangya Hospital of Central South University
Changsha, Hunan, China
RECRUITINGthe First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
RECRUITINGthe First Hospital of China Medical University
Shenyang, Liaoning, China
RECRUITINGThe Tenth People's Hospital of Shenyang
Shenyang, Liaoning, China
RECRUITINGthe First People's Hospital of Yunnan Provience
Kunming, Yunnan, China
RECRUITINGthe Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
RECRUITINGEfficacy of ultrasound elastography guided pleural biopsy versus traditional ultrasound-guided pleural biopsy for diagnosis of pleural effusion.
The diagnosis would be confirmed according to the pathological results.
Time frame: 7 days after the biopsy
Incidence rate of adverse events
Symptoms and signs
Time frame: 7 days after the biopsy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.